DuPont to Present New Perfluoroelastomer Solution in Italy

An image of a stock chart Credit: Shutterstock photo

DuPontDD is taking part at the upcoming Industrial Valve Summit in Bergamo, Italy to be held from May 24-25. The conference brings together people involved in valve technologies and flow control solutions to discuss technical challenges and opportunities, introduce pioneering technology, and share experiences.

At the event, DuPont will be presenting a paper on the results of its advanced testing solution to a key challenge faced by valve manufacturers -- the need to address both low temperature and high temperature requirements in a single sealing solution. The results have shown to significantly enhance low temperature sealing performance as well as reduce total sealing system cost.

Moreover, the products to be showcased by DuPont at the event include DuPont Kalrez perfluoroelastomer, parts which are resistant to more than 1800 chemicals and solvents and can retain high levels of elasticity and recovery, even after long-term exposure to harsh environments at elevated temperatures.

The company will also exhibit DuPont Vespel Polyimide (PI), properties of which will help to overcome severe sealing, wear and friction challenges. Also it can endure extremes of temperature and stand up to some of the world's harshest operating environments.

Additionally, the DuPont Vespel CR series include a range of composite materials that are designed to perform in hostile chemical environments associated with the oil and gas industry, particularly high-pressure pumps and valves used in hydrocarbon processing and refining.

DuPont has outperformed the Zacks categorized Chemicals-Diversified industry over the six months. The company's shares have rallied 9.95% over this period, compared with the industry's gain of around 9.3%.

DuPont kept its positive earnings surprise streak alive with a solid beat in first-quarter 2017. The company recorded adjusted earnings of $1.64 per share in the reported quarter, up 30% from $1.26 per share a year ago. The results topped the Zacks Consensus Estimate of $1.38. DuPont logged net sales of $7,743 million, up roughly 5% year over year on higher volumes and local prices. That also surpassed the Zacks Consensus Estimate of $7,539 million.

DuPont is focused on an aggressive cost-cutting strategy. Further, DuPont remains committed to introduce new higher-performing products to meet farmers' needs. It has numerous new products in its pipeline that should contribute to top line growth.

Also, the proposed mega-merger with Dow Chemical DOW is expected to deliver cost synergies of around $3 billion. The companies recently secured conditional regulatory approval in China and Brazil for the planned merger.

However, DuPont is exposed to raw material cost pressure and currency headwind, which can impact its results. The company also faces certain challenges in its nutrition & health and electronics businesses.

E.I. du Pont de Nemours and Company Price and Consensus

E.I. du Pont de Nemours and Company Price and Consensus | E.I. du Pont de Nemours and Company Quote

Zacks Rank & Key Picks

DuPont currently carries a Zacks Rank #3 (Hold).

Better-ranked companies in the basic materials space include BASF SE BASFY and The Chemours Company CC . Both the stocks sport a Zacks Rank #1 (Strong Buy). You can see the complete list of today's Zacks #1 Rank stocks here.

BASF has expected long-term growth of 8.6%.

Chemours has expected long-term growth of 15.5%.

Zacks' Hidden Trades

While we share many recommendations and ideas with the public, certain moves are hidden from everyone but selected members of our portfolio services. Would you like to peek behind the curtain today and view them?

Starting now, for the next month, I invite you to follow all Zacks' private buys and sells in real time from value to momentum...from stocks under $10 to ETF to option movers...from insider trades to companies that are about to report positive earnings surprises (we've called them with 80%+ accuracy). You can even look inside portfolios so exclusive that they are normally closed to new investors.

Click here for Zacks' secret trade>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

E.I. du Pont de Nemours and Company (DD): Free Stock Analysis Report

Dow Chemical Company (The) (DOW): Free Stock Analysis Report

BASF SE (BASFY): Free Stock Analysis Report

Chemours Company (The) (CC): Free Stock Analysis Report

To read this article on click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

More Related Articles

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.